The 5 linked references in paper V. Elagin V., D. Kostina A., O. Bratchikov I., M. Pokrovsky V., T. Pokrovskaya G., В. Елагин В., Д. Костина А., О. Братчиков И., М. Покровский И., Т. Покровская Г. (2018) “ИССЛЕДОВАНИЕ РЕНОПРОТЕКТИВНЫХ СВОЙСТВ ПРОИЗВОДНЫХ ЭРИТРОПОЭТИНА НА МОДЕЛИ ИШЕМИИ-РЕПЕРФУЗИИ ПОЧЕК // THE STUDY OF RENOPROTECTIVE PROPERTIES OF ERYTROPOETIN DERIVATIVES ON THE KIDNEY ISCHEMIA-REPERFUSION MODEL” / spz:neicon:ksma:y:2018:i:6:p:73-77

  1. Mao H., Katz N., Ariyanon W., Blanca-Martos L., Adýbelli Z., Giuliani A., Danesi T.H., Kim J.C., Nayak A., Neri M., Virzi G.M., Brocca A., Scalzotto E., Salvador L., Ronco C. Cardiac surgery-associated acute kidney injury. Cardiorenal Medicine. 2013; 3(3): 178-199. DOI:10.1159/000353134.
  2. Reznikov K.M., Gorbunova N.S., Kolesnichenko P.D., Tverskoy A.V., Kostina D.A., Bashkatova D.A., Nikitina V.A. Search of new pharmaceuticals on the basis of darbepoetin in the treatment of ischemic stroke (review of literature). Research result: pharmacology and clinical pharmacology. 2017; 3(1): 125-136. DOI: 10.18413/2500-235X-2017-3-1-125-136.
  3. Peresypkina A.A. Correction of ischemic optic neuropathy in rats by carbamylated darbepoetin. Research Result: Pharmacology and Clinical Pharmacology. 2018; 4(1): 43-50. DOI: 10.3897/ rrpharmacology.4.25262.
  4. Banaei S., Ahmadiasl N., Alihemmati A. Comparison of the Protective Effects of Erythropoietin and Melatonin on Renal Ischemia-Reperfusion Injury. Trauma Monthly. 2016; 21(3): e23005. DOI:10.5812/traumamon.23005.
  5. Zhuchenko M.A., Serebryakova M.V., Seregin Yu.A., Cherepushkin S.A., Lobanova N.V., Klishin A.A., Vologzhannikova A.A., Kazakov A.S., Permyakov S.E. Carbamylated Darbepoetin Alfa: Structure and Properties. Biotechnology. 2017; 33(4): 28-43. DOI: 10.21519/0234-2758-2017-33-4-28-43.